Vocca Raises $20M Series A Funding Led by Norrsken VC to Answer Medical Practices’ Phones With AI

Vocca, the Paris and New York-based healthcare voice AI startup, has raised $20 million in Series A funding led by Norrsken VC, with participation from Heal Capital, Speedinvest, and Firstminute Capital, along with angel investors including the founders of Alan and Datadog .

The round brings Vocca’s total disclosed funding to $25 million, following a $5.5 million seed round in September 2025 co-led by Speedinvest and Firstminute Capital. Vocca did not disclose its valuation.

The funding comes as Vocca scales rapidly: the company now serves 15,000 medical practitioners across 1,500 practices and more than 20 specialties in the US and Europe, up from 2,000 practitioners at its seed round just one year earlier .

Vocca Funding Overview By CREDX Media

Startup Name	Vocca
Founders	Eliott Hoffenberg (CEO)& Hugo Danet (CTO)
Founded	July 2024
HQ	Paris, France & New York, USA
Round	Series A Funding
Amount Raised	$20M
Valuation	Not disclosed
Category	Healthcare AI, Voice Agents, Medical Scheduling
Lead Investor	Norrsken VC
Key Investors	Heal Capital, Speedinvest, Firstminute Capital, angels including founders of Alan and Datadog
Previous Round	$5.5M Seed (September 2025)
Total Funding Raised	$25M
Employees	~40 (plans to hire 40 more by year-end)
Practitioners Served	15,000 across 1,500 practices
Monthly Conversations	1M+
Resolution Rate	70% average, 85%+ for top customers

💡 Use of Funds

• Scheduling Infrastructure: Building deeper scheduling capabilities for healthcare.
• Beyond Voice: Expanding into new patient interface channels beyond phone calls.
• Specialty Expansion: Supporting more medical specialties and complex workflows.
• US Expansion: Deepening presence in the United States .

Startup Overview: Vocca

What Vocca Is Building in Simple Words

Vocca builds AI phone assistants that answer patient calls for medical practices, book appointments, and handle administrative requests. The product is not a generic voice bot—it’s a specialty-aware scheduling engine that understands the rules attached to hundreds of examinations across dentistry, ophthalmology, medical imaging, general practice, and more .

• AI Medical Receptionist: Answers patient calls 24/7, books and reschedules appointments, sends reminders, handles routine inquiries, and escalates urgent or complex cases to staff .
• Specialty-Specific Logic: The scheduling engine applies the booking rules of each specialty—which practitioner, what preparation is required, which slot fits the patient’s request .
• EHR Integration: Connects to more than 20 scheduling and patient-management systems so practices keep the software they already use, enabling go-live in days rather than months .
• Compliance Built In: Hosts data separately in the US and EU, built to meet HIPAA requirements, operates as a HIPAA business associate, and uses infrastructure partners holding SOC 2, ISO 27001, and HDS certifications .

Why Vocca Matters

1. The Phone Is Healthcare’s Weak Link US health spending reached $5.3 trillion in 2024, and administrative costs made up roughly 25% of spending from 1999 through 2019, according to Oliver Wyman. Much of that work still happens on the phone .
2. Staff Are Burned Out and Calls Go Unanswered In 2022, 45.6% of US health workers reported feeling burned out often or very often, up from 31.9% in 2018. A 2023 analysis found 42% of calls to 22 US practices went unanswered during business hours .
3. Second Wave of Healthcare AI The first wave was documentation—ambient scribes that write clinical notes from consultations. The second wave, Vocca argues, is conversation, and it spreads faster because patients keep calling and staff keep their existing tools .
4. Traction Validates the Model Vocca’s conversation volume has grown tenfold to over 1 million per month, and revenue has grown sevenfold year-over-year. The company resolves 70% of conversations end-to-end without human involvement, with top customers exceeding 85% .

Startup Story: From Medical Admin Burden to AI Receptionist

Vocca was founded in July 2024 by Eliott Hoffenberg (CEO)& Hugo Danet (CTO) with a focused thesis: medical practices lose time, money, and patients to the phone .

The insight came from a simple observation. Despite the rise of online booking platforms like Doctolib in France, nearly 70% of appointments are still scheduled by phone. Secretaries juggle calls while managing front-desk tasks, documents, and patient flow. Many practices outsource to call centers, but that model brings its own problems—persistent wait times, inconsistent protocol execution, and frequent transfers back to the practice when cases deviate from the script .

Hoffenberg and Danet built Vocca to solve the actual bottleneck: not just answering calls, but completing the administrative work behind them. The scheduling engine understands specialty rules, integrates with existing software, and resolves most conversations without human intervention—while escalating the 20% that need judgment .

The pitch resonated quickly. Vocca grew from 2,000 to 15,000 practitioners in one year, expanded from Paris to New York, and attracted backing from Norrsken VC—Europe’s largest early-stage impact fund .

Our Take on Vocca

Vocca is solving the least glamorous problem in healthcare AI—phone calls—and that’s precisely why it matters.

Documentation was the first wave, and it worked because it was low-friction: doctors talk, AI writes. Conversation is harder. It requires real-time latency, specialty-specific logic, and seamless integration with legacy scheduling systems. Vocca’s scheduling engine is the differentiator—a generic voice bot that answers politely but books the wrong patient into the wrong slot creates more work than it saves .

The $20 million Series A is justified on traction: 7x revenue growth, 10x conversation volume, 15,000 practitioners, and a 70% end-to-end resolution rate. The company’s HIPAA compliance and separate US/EU data environments open enterprise doors that consumer voice AI cannot touch .

The real risk isn’t technical—Vocca has demonstrated production-scale operations. The risk is edge-case complexity. Adding more specialties and communication channels increases the number of exceptions the system must handle without turning staff into permanent supervisors of the automation. Norrsken and Speedinvest are betting Vocca can scale resolution rates even as it scales coverage .

Founder Background: The Team Building Healthcare’s Voice Layer

Eliott Hoffenberg (CEO)and Hugo Danet (CTO)founded Vocca in July 2024. Hoffenberg frames the product around execution speed and specialty accuracy: “Practices don’t ask us about price. They ask how fast we can deploy and how we handle their edge cases. Doctors want an AI that works like their best scheduler, follows the rules of their specialty to the letter, and fills more appointments without compromising on quality” .

The team grew from a handful of people at seed to roughly 40 today, split between Paris and New York. Vocca plans to hire another 40 by year-end—an execution test across product, integrations, deployment, and sales .

The Healthcare Voice AI Race Nobody Expected

Vocca enters a field that is filling quickly. Vapi sells voice infrastructure to developers. Prosper and others target similar healthcare call automation. But Vocca’s positioning is distinct: it’s not selling voice infrastructure—it’s selling a scheduling engine that happens to speak .

The competitive landscape breaks into three camps:

• Generic Voice AI Platforms: Sell to developers who build their own healthcare solutions. Lack specialty-specific scheduling logic.
• Outsourced Call Centers: Human-staffed, expensive, inconsistent quality, limited capacity.
• Vocca’s Middle Path: AI-native, specialty-aware, integrates with existing EHRs, resolves 70% autonomously, escalates the rest .

Vocca’s moat is the depth of its scheduling library—hundreds of examinations across 20+ specialties, each with its own rules, preparation requirements, and slot logic. Building that library requires time and domain expertise, not just voice technology .

Founder Intelligence: What Founders Can Learn from Vocca

• Solve the actual workflow, not the surface problem: Vocca doesn’t just answer calls—it books the right appointment, applies specialty rules, and integrates with existing software. The scheduling engine is the product.
• Growth follows resolution rate: Vocca’s 70% end-to-end resolution is the metric that matters. Practices don’t care about natural-sounding voices—they care about whether the AI completes the administrative work.
• Compliance is a feature gate: HIPAA compliance and separate US/EU data hosting unlock enterprise healthcare buyers that consumer AI platforms cannot serve.
• Speed of deployment beats price: Hoffenberg says practices ask “how fast can we deploy,” not “how much does it cost.” Reducing friction to days instead of months is the sales advantage.

Investor Intelligence: Why This Round Gets Premium Capital

Norrsken VC led the round—Europe’s largest early-stage impact fund, with a thesis around technology that solves real problems at scale .

Heal Capital brings healthcare sector expertise. Speedinvest and Firstminute Capital returned after co-leading the seed, signaling continued conviction .

The angel participation is particularly notable: founders of Alan (French health insurer) and Datadog (cloud monitoring) invested. These are operators who understand scaling healthcare and infrastructure businesses—their backing signals confidence in Vocca’s execution path .

The Road Ahead for Vocca

Expansion Targets

With $20 million in capital, Vocca will:

• Build deeper scheduling infrastructure for healthcare
• Expand beyond voice into new patient interface channels
• Support more specialties and complex workflows
• Deepen US presence with a New York office and hiring

Competitive Response

Expect:

• Generic voice AI platforms to add healthcare-specific scheduling features
• Outsourced call centers to integrate AI or face displacement
• New startups targeting specific specialties or workflows
• Vocca’s moat: specialty-specific scheduling library + EHR integrations + compliance infrastructure

Conclusion

Vocca’s $20 million Series A validates the thesis that conversation, not documentation, is the next wave of healthcare AI. The company’s 7x revenue growth, 15,000 practitioners, and 70% end-to-end resolution rate demonstrate that AI phone agents can complete real administrative work—not just answer politely.

Market tailwinds favor Vocca: burned-out staff, unanswered calls, and a $5.3 trillion healthcare system where administrative costs remain stubbornly high. The company’s scheduling engine and compliance infrastructure position it to capture a meaningful share of the quarter-million people employed to answer patient calls in the US alone.

For deep analysis of healthcare AI funding, voice agent innovation, and companies reshaping medical administration, explore CREDX Media for comprehensive coverage of startup funding trends, valuation intelligence, and founder playbooks.

Want the latest funding news and market insights delivered straight to your inbox? Subscribe to CredX Letters for verified deal terms, valuation benchmarks, and daily macro signals.

Frequently Asked Questions

1. What is Vocca’s total funding and latest round size?
Vocca has raised $25 million total. Its $20 million Series A was led by Norrsken VC in October 2026, following a $5.5 million seed round in September 2025 .

2. How much did Vocca raise in its Series A round and who led the investment?
Vocca raised $20 million in Series A funding led by Norrsken VC, with participation from Heal Capital, Speedinvest, Firstminute Capital, and angel investors including the founders of Alan and Datadog .

3. What is the valuation of Vocca?
Vocca did not disclose its post-money valuation in the Series A round. The company has raised $25 million in total disclosed funding .

4. Who are the major investors in Vocca?
Major investors include Norrsken VC (Series A lead), Heal Capital, Speedinvest, Firstminute Capital, and angels including the founders of Alan and Datadog .

5. What traction justifies Vocca’s Series A funding?
Vocca grew from 2,000 to 15,000 practitioners in one year, now handles over 1 million patient conversations monthly, and achieved 7x revenue growth. Its AI resolves 70% of conversations end-to-end without human involvement .

6. What was Vocca’s seed round size?
Vocca raised $5.5 million in seed funding in September 2025, co-led by Speedinvest and Firstminute Capital .

7. Who are Vocca’s founders?
Vocca was founded in July 2024 by Eliott Hoffenberg (CEO) and Hugo Danet (CTO). Hoffenberg emphasizes deployment speed and specialty-specific accuracy as the product’s core value .

8. What is Vocca’s business model?
Vocca operates a B2B SaaS model, selling AI phone assistants to medical practices on a subscription basis. Pricing is not publicly disclosed .

9. How does Vocca’s AI phone assistant work?
Vocca’s AI answers patient calls, books and reschedules appointments using specialty-specific scheduling rules, integrates with existing EHR and scheduling software, and escalates urgent or complex cases to human staff .

10. What are Vocca’s plans for the $20 million Series A capital?
Vocca will build deeper scheduling infrastructure, expand beyond voice into new patient interface channels, support more specialties, and deepen its US presence with hiring in New York .

11. How many practices use Vocca?
Vocca serves 15,000 practitioners across 1,500 practices and more than 20 specialties in the US and Europe .